Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review

BMC Endocrine Disorders

Valériade Cássia Sparapani¹  Marcos Venicio Esper²  Rebecca Ortiz La Banca³  Lucila Castanheira Nascimento⁴  Rhyquelle Rhibna Neris⁵  Carolina Spinelli Alvarenga⁵  Camila Lima Leal⁵  Denisse Cartagena-Ramos⁶  Miguel Fuentealba-Torres⁷ 

[1] Federal University of Santa Catarina, Florianopólis, Santa Catarina, Brazil;Interunit Doctoral Program in Nursing, University of São Paulo College of Nursing and the University of São Paulo at Ribeirão Preto College of Nursing, Ribeirão Preto, SP, Brazil;Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA;Maternal-Infant and Public Health Nursing Department, University of São Paulo at Ribeirão Preto College of Nursing, PAHO/WHO Collaborating Centre for Nursing Research Development, 3900 Av. Bandeirantes, Campus Universitário - Bairro Monte Alegre, 14040-902, Ribeirão Preto, São Paulo, Brazil;Public Health Nursing Graduate Program, University of São Paulo at Ribeirão Preto College of Nursing, Ribeirão Preto, SP, Brazil;Universidad Andrés Bello, Santiago, Chile;Universidad de los Andes, Santiago, Chile;

关键词: Child;    Adolescent;    Diabetes mellitus, type 1;    Insulin infusion systems;    Review;    Pediatric nursing;   

DOI  :  10.1186/s12902-022-00950-7

来源: Springer

【 摘 要 】

BackgroundAmong the treatments for type 1 diabetes mellitus (T1DM), Continuous Subcutaneous Insulin Infusion (CSII) is a device that infuses insulin through the subcutaneous tissue in an uninterrupted manner and that comes closest to the physiological secretion of insulin. The use of CSII can provide the family with greater security and children and adolescents have more autonomy in relation to the treatment of T1DM. There is a lack of reviews that systematically gather the mounting evidence about the use of CSII in children and adolescents with T1DM. Therefore, the aim of this review was to group and describe primary and secondary studies on the use of CSII in children and adolescents with T1DM.MethodsA systematic mapping review was performed based on searches in the following databases: PubMed, Embase, CINAHL, Lilacs and PsycINFO, using a combination of descriptors and keywords. The screening of the studies was carried out with the aid of the Rayyan software and reading in full was conducted independently by two reviewers. The data extraction of the studies was performed using an extraction tool adapted and validated by researchers specialized in diabetes. The data were analyzed according to the content analysis technique. The map from geocoding of the studies was produced using the ArcGis 10.5 software.ResultsA total of 113 studies were included in the review, including primary studies, literature reviews and gray literature publications. The content analysis of the results of the studies allowed for the identification of four categories: 1) metabolic control; 2) support networks; 3) benefits of using CSII; and 4) challenges of using CSII, each category having its respective subcategories. The review also made it possible to conduct a rigorous mapping of the literature on the use of CSII considering the location of development and the design of the studies.ConclusionsThe use of CSII should be indicated by health professionals able to prepare children, adolescents, and their families for the treatment of T1DM, and, despite being a technological device, it may not be suitable for the entire pediatric population.

【 授权许可】

CC BY